Christopher van Dyck MD
Professor of Psychiatry, Neurology, and Neurobiology; Director, Alzheimer's Disease Research Unit
Alzheimer's Disease; Cognitive Aging; Neuroimaging
christopher_vandyck faculty-clinics false true false Clinical Trials
Conditions Study Title Alzheimer's Disease Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo (Study H8A-MC-LZAX) Amnestic Mild Cognitive Impairment, Alzheimer's Disease, and Prodromal Alzheimer's Disease A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects with Amnesic Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal AD) (Protocol MK-8931-019) Cognition Disorders Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Study (Protocol H8A-MC-LZAZ/ADC-040-A4) Alzheimer's Disease A Phase 2 multi-center, randomized, double blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer's Disease (US202; Protocol Number: T817MAUS202 / ADC-047-TCAD).